Patient enrollment #SCCM2023
Patient characteristics #SCCM2023
These slides show that they did indeed have a difference in therapies given. #SCCM2023
There was no difference in the primary outcome of mortality or the secondary outcomes. #SCCM2023
There were also no differences in pre-specified subgroups. #SCCM2023
There were more patients in the restrictive group who needed ICU management and who had central catheters places. #SCCM2023
Safety of peripheral vasopressors #SCCM2023
Discussion #SCCM2023
Conclusions #SCCM2023
Next we have Dr. Somnath Bose (@somnathbose07) with “Association Between Unmet Non-Medication Needs After Hospital Discharge and Readmission or Death Among Acute Respiratory Failure Survivors: A Multicenter Prospective Cohort Study”! #SCCM2023
We are having more survivors who are dealing with PICS! #SCCM2023
Post-discharge needs can be classified into medication needs and non-medication needs. #SCCM2023
Gaps in knowledge #SCCM2023
Study aims #SCCM2023
Study design #SCCM2023
Inclusion and exclusion criteria #SCCM2023
Exposure and outcome #SCCM2023
Statistical analysis #SCCM2023
Sample size #SCCM2023
Results #SCCM2023
Baseline characteristics #SCCM2023
Non-medication discharge needs #SCCM2023
There were a lot of unmet non-medication discharge needs! #SCCM2023
They then looked at the drivers of unmet needs. #SCCM2023
Discussion #SCCM2023
Additional insights #SCCM2023
Study strengths #SCCM2023
Study limitations #SCCM2023
Conclusion #SCCM2023
Next up is Dr. Mekela Whyte-Nesfield with “Pediatric Critical Care-Associated Parental Traumatic Stress: Beyond the First Year”. #SCCM2023
Acute vs post-traumatic stress #SCCM2023
Epidemiology of stress in the PICU #SCCM2023
Effects of parental traumatic stress #SCCM2023
So we know we have post-traumatic parental stress in the PICU, but what we don't know is what happens to these parents after the first year. #SCCM2023
Inclusion and exclusion criteria #SCCM2023
Study tools #SCCM2023
Assessment timeline #SCCM2023
Demographics #SCCM2023
Retention #SCCM2023
Trajectory of PTSD #SCCM2023
Results #SCCM2023
Overall trends #SCCM2023
So when can we act? What are things to consider at different timepoints? #SCCM2023
Next steps #SCCM2023
And last in this session is “Effect of Early Nasal High-Flow for Children with Acute Hypoxemic Respiratory Failure: The PARIS-2 Randomized Clinical Trial” with Dr. Andreas Schibler! #SCCM2023
Baseline characteristics of infants with acute hypoxemic respiratory failure #SCCM2023
Study design #SCCM2023
Baseline characteristics #SCCM2023
Primary outcome was not significant. #SCCM2023
Secondary outcomes #SCCM2023
An alternate look at PICU admissions #SCCM2023
There was a lot of crossover of treatment due to intolerance of HFNC. #SCCM2023
How do PARIS 1 and PARIS 2 compare? #SCCM2023
Paris 1 secondary outcomes also showed a slightly longer hospital stay and higher rate of PICU admissions. #SCCM2023
Conclusions #SCCM2023
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.